Faculty profile

Remo Panaccione

ResearcherPhysiology and PharmacologyUniversity of Calgary

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Calgary directory, so their courses may be missing. Find their university profile.

Remo Panaccione

Researcher

Physiology and Pharmacology

Health Sciences

University of Calgary

Calgary, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
202 publications in the last five years, latest in 2026.
Senior (last) author on 22 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2026.
Supervisor on 1 trainee award (1 CIHR), most recently in 2016.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

397

Publications

2,343

Citations

100

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Autologous Cell Transfer Therapy Barrier Function Extracellular Matrix (Ecm)Gut Microbiota Il-4 Educated Human Macrophage Inflammatory Bowel Disease Interleukin-6 Models Of Colitis

Latest papers

Effectiveness and Safety of Advanced Combination Treatment in Patients With Refractory Inflammatory Bowel Disease or Concomitant Immune-Mediated Disease or Extraintestinal Manifestations: A Multicenter Canadian Study
American Journal of Gastroenterology · 2026
β-Glucan and Inulin Estimated Intake Are Associated With Reduced Risk of Crohn's Disease, Improved Gut Barrier and Systemic Inflammation Markers, and Multi-Omic Signatures in a High-Risk Cohort
Gastroenterology · 2026
Serum IgG Response to a Conserved Domain of Commensal Flagellins Predicts Future Risk of Crohn’s Disease in First-Degree Relatives
Clinical Gastroenterology and Hepatology · 2026

All 397 publications

Latest funding

Human M(IL4)s as an autologous anti-colitic therapy
CIHR · 2026 · Principal investigator
$1,162,800
IMAGINE (Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects) SPOR Chronic Disease Network - Knowledge Mobilization & Implementation Science Phase 2
CIHR · 2021 · Principal investigator
$3,745,000
Serological Testing to Outline Protocols for COVID19 in Inflammatory Bowel Disease: STOP COVID-19 in IBD
CIHR · 2020 · Co-investigator
$636,750

All 7 grants and awards

From the 150 most recent of 397 publications.

Effectiveness and Safety of Advanced Combination Treatment in Patients With Refractory Inflammatory Bowel Disease or Concomitant Immune-Mediated Disease or Extraintestinal Manifestations: A Multicenter Canadian Study

Solitano V, Ogunsakin RE, Yuan Y, Bernstein CN, Bessissow T, Bressler B, Hoentjen F, van Lierop L, Leung Y, Ma C

American Journal of Gastroenterology202612 citations

DOI: 10.14309/ajg.0000000000003573

β-Glucan and Inulin Estimated Intake Are Associated With Reduced Risk of Crohn's Disease, Improved Gut Barrier and Systemic Inflammation Markers, and Multi-Omic Signatures in a High-Risk Cohort

Xue M, McShane C, Kim J, Khorasaniha R, Leibovitzh H, Shao J, Chen R, Jeong S, Madsen KL, Griffiths AM

Gastroenterology20263 citations

DOI: 10.1053/j.gastro.2026.05.006

Serum IgG Response to a Conserved Domain of Commensal Flagellins Predicts Future Risk of Crohn’s Disease in First-Degree Relatives

Wu RY, Xue M, Zhao Q, Jeong S, Griffiths AM, Dieleman LA, Steinhart AH, Aumais G, Bressler B, Panaccione R

Clinical Gastroenterology and Hepatology20263 citations

DOI: 10.1016/j.cgh.2025.12.006

Intestinal ultrasound to detect postoperative recurrence in patients with Crohn's disease: an international, multidisciplinary, RAND/UCLA appropriateness method study

Ma C, Albashir S, Allocca M, de Buck van Overstraeten A, Kotze PG, Lu C, Maaser C, Maconi G, Panaccione R, Regueiro M

The Lancet Gastroenterology and Hepatology20263 citations

DOI: 10.1016/s2468-1253(26)00082-8

Pre-Crohn’s Disease Stool From Discordant Siblings Promotes the Development of Colitis in Germ-Free Mice

Dang CP, Chen-Liaw A, Xue M, Luchak A, Mu K, Li Q, Ren MY, Lee S-H, Moayyedi P, Griffiths AM

Gastroenterology20261 citations

DOI: 10.1053/j.gastro.2026.03.023

Serum thiol redox-related alterations in asymptomatic first-degree relatives are associated with future Crohn's disease

Mu K, Xue M, Huynh HQ, Griffiths AM, Turner D, Moayyedi P, Steinhart AH, Dieleman LA, Deslandres C, Bitton A

Redox Biology2026

DOI: 10.1016/j.redox.2026.104207

Childhood exposure to a sibling with Crohn's disease alters gut microbiome and Crohn's disease susceptibility.

Chen R, Kim HJ, Bushra M, Phi Dang C, Li Q, Espin-Garcia O, Huynh HQ, Jacobson K, Bitton A, Panaccione R

Gut2026

DOI: 10.1136/gutjnl-2026-339257

Patient-reported Outcomes in Clinical Trials of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

Hanzel J, Yuan Y, Goodwin SW, Nardone OM, Roseira J, Solitano V, Vuyyuru SK, Leong RW, Sands BE, Turner D

Clinical Gastroenterology and Hepatology2026

DOI: 10.1016/j.cgh.2026.05.015

Underevaluation of bowel urgency in clinical care: patient experiences and outcomes in ulcerative colitis: a retrospective cohort study

Gill PK, Finch H, Stein L, Kaplan GG, Lu C, Novak KL, Seow CH, Ingram RJM, Martin M-L, Martin M

Inflammatory Bowel Diseases2026

DOI: 10.1093/ibd/izag102

Nationalization of clinical care pathways for inflammatory bowel disease management in Canada

Chappell KD, Tausif A, Seow CH, Panaccione R, Lim A, Tersigni C, Nguyen GC, Wang H, Fehr W, Bitton A

Journal of the Canadian Association of Gastroenterology2026

DOI: 10.1093/jcag/gwaf043

Human M(IL4)s as an autologous anti-colitic therapy

Principal investigatorCIHR2026Project Grant

Principal investigators: McKay, Derek M; Panaccione, Remo

Keywords: Autologous Cell Transfer Therapy; Barrier Function; Extracellular Matrix (Ecm); Gut Microbiota; Il-4 Educated Human Macrophage; Inflammatory Bowel Disease; Interleukin-6; Models Of Colitis; Regulatory Macrophage

$1,162,800

IMAGINE (Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects) SPOR Chronic Disease Network - Knowledge Mobilization & Implementation Science Phase 2

Principal investigatorCIHR2021SPOR Networks - Knowledge Mobilization and Implementation Science

Principal investigators: Moayyedi, Paul; Calliou, Skylin N; Daley, Kimberlee; De Nino, Alysia; Desjarlais, Rhonda; Marsiglio, Megan L; Munro, Sandra; Baumgart, Daniel C; Bercik, Premysl; Bernstein, Charles N; de Souza, Russell J; Dieleman, Levinus A; D'Silva, Adrijana; Ghia, Jean-Eric; Graff, Lesley A; Jones, Meaghan J; Kao, Dina H; Lavis, John N; Leontiadis, Grigorios; Libertucci, Josie; Ma, Christopher; Madsen, Karen L; Marshall, Deborah A; Narula, Neeraj; Nguyen, Geoffrey C; Otley, Anthony R; Panaccione, Remo; Pena-Sanchez, Juan-Nicolas; Presseau, Justin; Ruzycki, Shannon M; Surette, Michael G; Swain, Mark G; Tandon, Puneeta; Taylor, Valerie Hannah; Tremblay, Melissa; Tripp, Dean A; Vanner, Stephen J; Verdu, Elena F; Walters, Thomas D; Wine, Eytan

Keywords: Anxiety; Depression; Diet; Implementation Science; Inflammatory Bowel Disease; Irritable Bowel Syndrome; Knowledge Mobilization; Microbiome; Patient Orientated Research

$3,745,000

Serological Testing to Outline Protocols for COVID19 in Inflammatory Bowel Disease: STOP COVID-19 in IBD

Co-investigatorCIHR2020Op Grant: COVID-19 Rapid Research FO - Social Policy and Public Health Responses

Principal investigators: Kaplan, Gilaad G; Mawani, Mina; Morrin, Louise; Benchimol, Eric I; Munro, Sandra; Tipples, Graham A

Keywords: Covid-19; Crohn'S Disease; Immunocompromised; Inflammatory Bowel Disease; Knowledge Translation; Modeling; Sars-Cov-2; Serology; Seropositive; Ulcerative Colitis

$636,750

Development of a Core Outcomes Set for Clinical Trials in Inflammatory Bowel Disease: An International Collaboration

SupervisorCIHR2016Fellowship - Priority Announcement: Gastroenterology

Principal investigators: Ma, Christopher

Keywords: Clinical Trials; Core Outcome Sets; Crohn'S Disease; Delphi Method; Inflammatory Bowel Disease; Ulcerative Colitis

$55,000

A multidisciplinary approach to target chronic inflammation of the gut, liver and joint

Co-investigatorCIHR2012Team Grant: Health Challenges in Chronic Inflammation Initiative (LOI)

Principal investigators: Eksteen, Johannes A

Keywords: Autoimmune Hepatitis; Chemokines; Chrominc Inflammation; Gut Permeability; Ibd; Primary Sclerosing Cholangitis; Seronegative Arthritis

$13,000

The role of the Intestinal Microbiome in Post-Operative Recurrence of Crohn's Ileocolitis

Co-investigatorCIHR2009Canadian Microbiome Initiative - LOI

Principal investigators: Madsen, Karen L; Fedorak, Richard N; Vogel, Hans (Harm) J

Keywords: Inflammatory Bowel Disease; Metabolomics; Metagenomics

Oral Methotrexate for Active Crohn's Disease

Co-investigatorCIHR2009Operating Grant - PA: Inst of Nutrition, Metabolism and Diabetes -Bridge Funding

Principal investigators: Feagan, Brian G

Keywords: Crohn'S Disease; Methotrexate; Pharmacogenomics; Pharmacokinetics; Placebo-Controlled; Randomized

$100,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2026

Subject: Prospective PhD student: Autologous Cell Transfer Therapy Dear Professor Panaccione, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Effectiveness and Safety of Advanced Combination Treatment in Patients With Refractory Inflammatory Bowel Disease or Concomitant Immune-Mediated Disease or Extraintestinal Manifestations: A Multicenter Canadian Study" (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Human M(IL4)s as an autologous anti-colitic therapy" (2026), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Remo Panaccione

Research

Latest papers

Latest funding

Effectiveness and Safety of Advanced Combination Treatment in Patients With Refractory Inflammatory Bowel Disease or Concomitant Immune-Mediated Disease or Extraintestinal Manifestations: A Multicenter Canadian Study

β-Glucan and Inulin Estimated Intake Are Associated With Reduced Risk of Crohn's Disease, Improved Gut Barrier and Systemic Inflammation Markers, and Multi-Omic Signatures in a High-Risk Cohort

Serum IgG Response to a Conserved Domain of Commensal Flagellins Predicts Future Risk of Crohn’s Disease in First-Degree Relatives

Intestinal ultrasound to detect postoperative recurrence in patients with Crohn's disease: an international, multidisciplinary, RAND/UCLA appropriateness method study

Pre-Crohn’s Disease Stool From Discordant Siblings Promotes the Development of Colitis in Germ-Free Mice

Serum thiol redox-related alterations in asymptomatic first-degree relatives are associated with future Crohn's disease

Childhood exposure to a sibling with Crohn's disease alters gut microbiome and Crohn's disease susceptibility.

Patient-reported Outcomes in Clinical Trials of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

Underevaluation of bowel urgency in clinical care: patient experiences and outcomes in ulcerative colitis: a retrospective cohort study

Nationalization of clinical care pathways for inflammatory bowel disease management in Canada

Human M(IL4)s as an autologous anti-colitic therapy

IMAGINE (Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects) SPOR Chronic Disease Network - Knowledge Mobilization & Implementation Science Phase 2

Serological Testing to Outline Protocols for COVID19 in Inflammatory Bowel Disease: STOP COVID-19 in IBD

Development of a Core Outcomes Set for Clinical Trials in Inflammatory Bowel Disease: An International Collaboration

A multidisciplinary approach to target chronic inflammation of the gut, liver and joint

The role of the Intestinal Microbiome in Post-Operative Recurrence of Crohn's Ileocolitis

Oral Methotrexate for Active Crohn's Disease

Frequent collaborators

Christopher Ma

Vipul Jairath

John Kenneth Marshall

Alain Bitton

Paul Moayyedi

Kenneth Croitoru

Cathy Lu

Guangyong Zou

Wei Xu

Osvaldo Espin Garcia

Sanjay Murthy

Waqqas Afif

Brian Feagan

Humberto Jijon

Neeraj Narula

Anthony Otley

Jennifer Jones

Reena Khanna

Michael Surette

David Mack

Anne Griffiths

Grigorios Leontiadis

Allan Donner

Osvaldo Espin Garcia

Konstantin Shestopaloff

Tiffany Fitzpatrick

Alaa Rostom

Jeffrey McCurdy

Heather Armstrong